{"date":"2025-09-14","count":2,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6620-2025-09-14-1938-uf8tda","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-09-14","time":"19:38:14","subject":"代子公司Handa Pharmaceuticals, LLC公告與美國反壟斷案全部直接購買者原告達成和解協議且本反壟斷案全案終結","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-09-14 19:38，「代子公司Handa Pharmaceuticals, LLC公告與美國反壟斷案全部直接購買者原告達成和解協議且本反壟斷案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-09-14-1030-7mi2k3","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-09-14","time":"10:30:03","subject":"公告本公司受邀參加元富證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-09-14 10:30，「公告本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}